Leigh Ann Winick

Mar 13, 2024 | cbsnews.com | Sara Moniuszko |Leigh Ann Winick

U.S. strategy to end the HIV epidemic Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know it's an option. It's called pre-exposure prophylaxis, or PrEP,  and it is about 99% effective to prevent HIV infection through sexual contact when taken as prescribed.

Jan 26, 2024 | news.yahoo.com | Stephen Stock |Leigh Ann Winick |Sara Moniuszko

Measles was officially declared eradicated in the U.S. more than 20 years ago, but new outbreaks of the disease are popping up — and experts say declining vaccination rates are jeopardizing herd immunity and increasing the risk. In Philadelphia, nine cases were reported after a cluster started in a hospital and spread to other medical facilities and a day care center. Measles is a highly contagious and potentially deadly virus that causes a tell-tale rash.

Jan 23, 2024 | cbsnews.com | Stephen Stock |Leigh Ann Winick |Sara Moniuszko

What's causing measles outbreaks? Measles was officially declared eradicated in the U.S. more than 20 years ago, but new outbreaks of the disease are popping up — and experts say declining vaccination rates are jeopardizing herd immunity and increasing the risk. In Philadelphia, nine cases were reported after a cluster started in a hospital and spread to other medical facilities and a day care center.

Dec 11, 2023 | autos.yahoo.com | Jonathan LaPook |Leigh Ann Winick |Analisa Novak

The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease. The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease.

Dec 11, 2023 | yahoo.com | Jonathan LaPook |Leigh Ann Winick |Analisa Novak

The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease. The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease.